Qilian International Holding Group (BGM) Competitors $8.15 +0.15 (+1.88%) (As of 11:58 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends BGM vs. SKYE, STTK, TELO, GALT, AMLX, GBIO, ME, CVKD, VTYX, and LLYShould you be buying Qilian International Holding Group stock or one of its competitors? The main competitors of Qilian International Holding Group include Skye Bioscience (SKYE), Shattuck Labs (STTK), Telomir Pharmaceuticals (TELO), Galectin Therapeutics (GALT), Amylyx Pharmaceuticals (AMLX), Generation Bio (GBIO), 23andMe (ME), Cadrenal Therapeutics (CVKD), Ventyx Biosciences (VTYX), and Eli Lilly and Company (LLY). These companies are all part of the "pharmaceutical preparations" industry. Qilian International Holding Group vs. Skye Bioscience Shattuck Labs Telomir Pharmaceuticals Galectin Therapeutics Amylyx Pharmaceuticals Generation Bio 23andMe Cadrenal Therapeutics Ventyx Biosciences Eli Lilly and Company Skye Bioscience (NASDAQ:SKYE) and Qilian International Holding Group (NASDAQ:BGM) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, community ranking, dividends and earnings. Is SKYE or BGM more profitable? Qilian International Holding Group's return on equity of 0.00% beat Skye Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Skye BioscienceN/A -111.83% -80.69% Qilian International Holding Group N/A N/A N/A Do institutionals & insiders hold more shares of SKYE or BGM? 21.1% of Skye Bioscience shares are held by institutional investors. 0.7% of Skye Bioscience shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, SKYE or BGM? Skye Bioscience has a beta of 1.8, meaning that its stock price is 80% more volatile than the S&P 500. Comparatively, Qilian International Holding Group has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Does the MarketBeat Community prefer SKYE or BGM? Skye Bioscience and Qilian International Holding Group both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformSkye BioscienceN/AN/AQilian International Holding GroupN/AN/A Which has higher valuation & earnings, SKYE or BGM? Qilian International Holding Group has higher revenue and earnings than Skye Bioscience. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSkye BioscienceN/AN/A-$37.65MN/AN/AQilian International Holding Group$46.47MN/A-$7.78MN/AN/A Does the media favor SKYE or BGM? In the previous week, Skye Bioscience had 8 more articles in the media than Qilian International Holding Group. MarketBeat recorded 8 mentions for Skye Bioscience and 0 mentions for Qilian International Holding Group. Qilian International Holding Group's average media sentiment score of 1.87 beat Skye Bioscience's score of 0.43 indicating that Qilian International Holding Group is being referred to more favorably in the news media. Company Overall Sentiment Skye Bioscience Neutral Qilian International Holding Group Very Positive Do analysts prefer SKYE or BGM? Skye Bioscience currently has a consensus target price of $18.40, suggesting a potential upside of 251.15%. Given Skye Bioscience's higher possible upside, analysts plainly believe Skye Bioscience is more favorable than Qilian International Holding Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Skye Bioscience 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummarySkye Bioscience beats Qilian International Holding Group on 6 of the 11 factors compared between the two stocks. Ad True Gold RepublicCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold. Click here now to get your free 'Protect Your Wealth' Guide. Get Qilian International Holding Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGM vs. The Competition Export to ExcelMetricQilian International Holding GroupPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$7.99B$5.67B$8.48BDividend YieldN/A4.45%4.95%4.07%P/E RatioN/A19.56147.2918.70Price / SalesN/A242.051,651.7572.70Price / Cash19.5437.7837.1731.47Price / Book1.066.044.934.58Net Income-$7.78M$153.43M$115.08M$225.05M7 Day Performance29.57%10.02%6.33%5.51%1 Month Performance36.74%14.78%7.06%5.86%1 Year PerformanceN/A25.03%31.51%13.77% Qilian International Holding Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SKYESkye Bioscience1.6291 of 5 stars1.63 / 5 stars$6.00flat$18.40+206.7%+144.9%$182.04MN/A0.0011Gap UpSTTKShattuck Labs2.4085 of 5 stars2.41 / 5 stars$3.81+3.3%$10.67+180.0%+84.3%$181.85M$1.66M-1.97100Positive NewsTELOTelomir Pharmaceuticals0 of 5 stars0.00 / 5 stars$6.07+2.2%N/AN/A$179.73MN/A0.001Gap UpGALTGalectin Therapeutics2.1986 of 5 stars2.20 / 5 stars$2.87+5.9%$11.00+283.3%+37.6%$178.74MN/A-3.889Positive NewsAMLXAmylyx Pharmaceuticals4.1065 of 5 stars4.11 / 5 stars$2.62+5.2%$17.60+571.8%-84.6%$178.18M$298.76M-2.45200Insider BuyingGap UpGBIOGeneration Bio2.3883 of 5 stars2.39 / 5 stars$2.60+2.8%$7.50+188.5%-35.9%$172.98M$13.17M-1.02150Gap UpME23andMe1.3924 of 5 stars1.39 / 5 stars$0.34+4.5%$0.47+38.2%-67.1%$166.69M$199.19M-0.24770Gap UpCVKDCadrenal Therapeutics1.226 of 5 stars1.23 / 5 stars$10.21-4.6%$0.23-97.7%N/A$163.44MN/A-32.934Analyst RevisionNews CoverageHigh Trading VolumeVTYXVentyx Biosciences2.9678 of 5 stars2.97 / 5 stars$2.29+6.5%$8.29+261.8%-93.9%$161.44MN/A-0.7130News CoverageGap UpLLYEli Lilly and Company4.7585 of 5 stars4.76 / 5 stars$923.71-1.2%$977.35+5.8%+58.5%$877.92B$34.12B136.0443,000Analyst Forecast Related Companies and Tools Related Companies: SKYE Competitors STTK Competitors TELO Competitors GALT Competitors AMLX Competitors GBIO Competitors ME Competitors CVKD Competitors VTYX Competitors LLY Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BGM) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qilian International Holding Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Qilian International Holding Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BGM Stock Alerts